Rights and permissions
About this article
Cite this article
RSVIG not recommended in infants without lung disease. Pharmacoecon. Outcomes News 166, 10 (1998). https://doi.org/10.1007/BF03277597
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03277597